Anmat does not remove breast implants banned in France for cancer, but monitors them

The appearance of lymphoma cases in patients with bad implants in France led to the ban of six models of prostheses considered likely to cause cancer. In Argentina, the Administration stated that it "oversees the products in question".

"At the present time, after evaluating the available information, the cause of lymphoma can not be reliably established.Other possible causes are implants with a textured / rough surface and / or a surface coated with polyurethane, the genetic basis of people or possible contamination are mentioned, "he said in a statement.

This is why ANMAT has so far not ordered the withdrawal of implants from the market, in accordance with the measures adopted by the European Regulatory Agencies (with the exception of the France), the United States Food and Drug Administration (FDA) and, among others, Australia's Therapeutic Goods Administration (TGA) ".

The medical control agency said: "People who have bad implants should continue the usual medical examinations and, if they feel an unexpected effect or problem (sudden increase in bad volume, capsular contracture, ulceration, nodule / mbad localized dermatological pain, inflammation, or alterations), you should see your doctor for examination and badessment of the situation. "However, this type of lymphoma badociated with bad implants is a rare condition.

"It is important to remember that health professionals evaluate each of their patients in particular and inform them of the possible risks badociated with the use of this type of product.They also badess in each case the relevance of the patient. use and follow-up It is important to remind patients that they should follow their doctor's instructions and carry out routine checks, especially in the face of the occurrence of certain adverse effects for their early badessment. " -he adds.

Finally, he announced that he would meet with representatives of scientific and technical companies to continue to follow the evolution of the issue. Likewise, it will strengthen interaction with foreign health agencies to evaluate actions to be implemented and update information, as appropriate.

If you have any questions or have any questions, you can contact ANMAT Respond at 0-800-333-1234, Monday to Friday, from 8:00 am to 6:00 pm and Saturdays, Sundays and public holidays from 10h to 18h. or by email to [email protected]

Source: Infobae

EB